Cure TV

CURE spoke with Dr. Marina Kremyanskaya about the treatment landscape for patients with polycythemia vera.

After more than 30 years since she was first diagnosed with a myeloproliferative neoplasm, Nona Baker is hopeful for the future thanks to current clinical trial landscape.

Dr. Pamela L. Kunz sat down for an interview with CURE to discuss resources and ongoing initiatives that may help patients with this disease.

Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered unattainable.

Nona Baker received a diagnosis of essential thrombocythemia in 1991, followed by polycythemia vera in 2004.

Young adults with newly diagnosed cancer may feel overwhelmed, but open communication with doctors and support groups can help them feel less alone.

Dr. Joshua Sabai spoke with Dr. Chandler Park about the latest advances in kidney cancer, highlighting clinical trials that are shaping care for patients.

In honor of Lung Cancer Awareness Month, CURE spoke with Dr. Daniel J. Boffa about how the understanding of lung cancer is evolving beyond smoking.

Following the 2025 ESMO Congress, Dr. Joshua Saba sat down with Dr. Chandler Park to discuss recent advances in prostate cancer care.

After her own breast cancer treatment, Maureen advocated for legislation to make scalp cooling more accessible for patients seeking to preserve their hair.

Ten years after first being diagnosed with breast cancer, Cynthia Malaran said she still faces some side effects from treatment, but she has found strategies for coping.

Tracy Milgram-Posner sat down for an interview with CURE to discuss BRCAStrong and the impact she hopes to make for anyone with breast cancer.

Dr. Joshua Sabari, Dr. Petros Grivas, and Dr. Chandler Park discuss new developments in perioperative therapy for muscle-invasive bladder cancer.

Four-time non-Hodgkin lymphoma survivor Shell Rowe knows very well about the importance of finding the lighthearted side of an otherwise serious situation.

Experts highlight perioperative Padcev plus Keytruda in bladder cancer, showing potential practice-changing results from ESMO 2025 for patients.

Dr. Mariano Provencio says many patients still face recurrence after lung cancer surgery and perioperative treatment aims to improve survival.

In recognition of Pancreatic Cancer Awareness Month, Dr. Suneel Kamath discussed the importance of directing support toward cancers with the unmet needs.

Steve Brown and Lisa Booth sat down for a joint interview with CURE to discuss the future of patient-driven artificial intelligence in cancer care.

Jeannine Walston, who has contributed to CURE since 2015, was diagnosed with a brain tumor in March 1998.

Specialized sarcoma centers enhance coordinated care for young adults, although travel and financial barriers persist, Dr. Vinayak Venkataraman stated.

‘Coping With Cancer in Early Adulthood’ addresses issues of patients 18 to 49 years old.

CURE attended the Hairy Cell Leukemia Foundation 2025 Conference where medical experts gathered to discuss advances in research and patient care.

As Liver Cancer Awareness Month ends, Drs. Vogel and Yarchoan highlight the urgent need for greater awareness, support and resources for liver cancer.

CURE spoke with Dr. Rosario Ligestri and Dr. Anna Berkenblit about the rising rate of pancreatic cancer in relatively younger adults.

Dr. Dima El-Sharkawi discusses how hairy cell leukemia typically presents in patients and the challenges clinicians face in identifying the disease early.

For Silvia Davis, a breast cancer diagnosis at the age of 36 led to a fertility preservation journey that resulted in her son, John.

Dr. Anjana Pillai says treatment depends on stage and health, with surgery, transplant, local therapy or systemic drugs to help people live longer.

Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as gastrointestinal stromal tumor (GIST).